Immunic, Inc.
IMUX
$12.06
-$0.13-1.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.55% | -8.19% | 3.32% | -6.34% | -6.85% |
| Total Depreciation and Amortization | -8.59% | 4.64% | 25.37% | 31.97% | 42.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 111.14% | 55.97% | -38.73% | -34.22% | -44.72% |
| Change in Net Operating Assets | 92.72% | 80.31% | 456.97% | -40.40% | -57.87% |
| Cash from Operations | 2.69% | 1.50% | -1.23% | -18.01% | -24.60% |
| Capital Expenditure | -141.91% | 58.57% | 39.02% | 64.08% | 67.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -141.91% | 58.57% | 39.02% | 64.08% | 67.62% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 207.08% | 321,545.78% | 23,833.21% | 8,151.70% | 5,991.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -212,350.00% | -- | -- | -- |
| Cash from Financing | 187.86% | 330,054.55% | -12.03% | -12.62% | -12.95% |
| Foreign Exchange rate Adjustments | -431.76% | -92.67% | 139.65% | -81.23% | 265.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 509.17% | 307.60% | -83.40% | -3,773.62% | -1,114.48% |